A Study Of IV Casopitant For The Prevention Of Chemotherapy Induced Nausea And Vomiting.

PHASE3CompletedINTERVENTIONAL
Enrollment

710

Participants

Timeline

Start Date

March 10, 2008

Primary Completion Date

April 13, 2009

Study Completion Date

April 13, 2009

Conditions
Nausea and Vomiting, Chemotherapy-Induced
Interventions
DRUG

Casopitant

Experimental NK-1 receptor antagonist

DRUG

Dexamethasone

Standard antiemetics

DRUG

Placebo

Placebo to match IV casopitant

DRUG

Ondansetron

Standard antiemetics

Trial Locations (96)

1106

GSK Investigational Site, Budapest

1125

GSK Investigational Site, Budapest

1340

GSK Investigational Site, Ottignies

1756

GSK Investigational Site, Sofia

2820

GSK Investigational Site, Bonheiden

5700

GSK Investigational Site, Gyula

8200

GSK Investigational Site, Veszprém

8310

GSK Investigational Site, Assebroek

9000

GSK Investigational Site, Ghent

9010

GSK Investigational Site, Varna

9700

GSK Investigational Site, Shumen

10467

GSK Investigational Site, The Bronx

16132

GSK Investigational Site, Genoa

22081

GSK Investigational Site, Hamburg

22457

GSK Investigational Site, Hamburg

23562

GSK Investigational Site, Lübeck

25421

GSK Investigational Site, Pinneberg

27103

GSK Investigational Site, Winston-Salem

29150

GSK Investigational Site, Sumter

29464

GSK Investigational Site, Mt. Pleasant

29926

GSK Investigational Site, Hilton Head Island

30171

GSK Investigational Site, Hanover

33614

GSK Investigational Site, Tampa

33705

GSK Investigational Site, St. Petersburg

34119

GSK Investigational Site, Kassel

35128

GSK Investigational Site, Padua

38114

GSK Investigational Site, Braunschweig

39104

GSK Investigational Site, Magdeburg

45122

GSK Investigational Site, Essen

45657

GSK Investigational Site, Recklinghausen

50139

GSK Investigational Site, Florence

52146

GSK Investigational Site, Würselen

59405

GSK Investigational Site, Great Falls

63739

GSK Investigational Site, Aschaffenburg

65109

GSK Investigational Site, Jefferson City

65812

GSK Investigational Site, Bad Soden

70809

GSK Investigational Site, Baton Rouge

71301

GSK Investigational Site, Alexandria

71913

GSK Investigational Site, Hot Springs

75137

GSK Investigational Site, Duncanville

78412

GSK Investigational Site, Corpus Christi

79106

GSK Investigational Site, Freiburg im Breisgau

80131

GSK Investigational Site, Napoli

81241

GSK Investigational Site, Munich

82100

GSK Investigational Site, Benevento

83100

GSK Investigational Site, Avellino

84403

GSK Investigational Site, Ogden

85028

GSK Investigational Site, Rionero in Vulture (PZ)

85100

GSK Investigational Site, Potenza

86150

GSK Investigational Site, Augsburg

89081

GSK Investigational Site, Ulm

89125

GSK Investigational Site, Reggio Calabria

92501

GSK Investigational Site, Riverside

92708

GSK Investigational Site, Fountain Valley

92879

GSK Investigational Site, Corona

95028

GSK Investigational Site, Hof

95125

GSK Investigational Site, Catania

97070

GSK Investigational Site, Würzburg

115478

GSK Investigational Site, Moscow

197758

GSK Investigational Site, Saint Petersburg

420029

GSK Investigational Site, Kazan'

443066

GSK Investigational Site, Samara

21215-5271

GSK Investigational Site, Baltimore

02135

GSK Investigational Site, Boston

01608

GSK Investigational Site, Worcester

78463-3069

GSK Investigational Site, Corpus Christi

05401

GSK Investigational Site, Burlington

P6A 2C4

GSK Investigational Site, Sault Ste. Marie

P7B 6V4

GSK Investigational Site, Thunder Bay

M5G 1X5

GSK Investigational Site, Toronto

C1A 8T5

GSK Investigational Site, Charlottetown

J4V 2H1

GSK Investigational Site, Greenfield Park

H7M 3L9

GSK Investigational Site, Laval

H1T 2M4

GSK Investigational Site, Montreal

G5L 5T1

GSK Investigational Site, Rimouski

J1H 5N4

GSK Investigational Site, Sherbrooke

625 00

GSK Investigational Site, Brno

656 91

GSK Investigational Site, Brno

430 12

GSK Investigational Site, Chomutov

580 22

GSK Investigational Site, Havlíčkův Brod

100 00

GSK Investigational Site, Prague

180 81

GSK Investigational Site, Prague

513 01

GSK Investigational Site, Semily

07743

GSK Investigational Site, Jena

07100

GSK Investigational Site, Sassari

05100

GSK Investigational Site, Terni

129 128

GSK Investigational Site, Moscow

143 423

GSK Investigational Site, Moscow Region

975 17

GSK Investigational Site, Banská Bystrica

833 10

GSK Investigational Site, Bratislava

041 91

GSK Investigational Site, Košice

058 01

GSK Investigational Site, Poprad

410-769

GSK Investigational Site, Gyeonggi-do

120-752

GSK Investigational Site, Seoul

135-710

GSK Investigational Site, Seoul

138-736

GSK Investigational Site, Songpa-gu, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY